Notably, recent accumulating evidence indicates the broad application prospects and values of the CRISPR-Cas13 system, a specific RNA-targeting platform, in viral (i.e., SARS-CoV-2) infection diagnosis and treatment. Sign in to download hi-res image Figure 1. Genome coding potential and ...
et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann. Intern. Med. 172, 577–582 (2020). Article PubMed Google Scholar Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-...
The outbreak of 2019 novel coronavirus disease (Covid-19) caused by SARS-CoV-2 has spread rapidly, inducing a progressive growth in infected patients number. Social isolation (lockdown) has been assessed to prevent and control virus diffusion, leading to
Gilead. (2020) Remdesivir compassionate use application. https://rdvcugilead.com/ Golonka RM, Saha P, Yeoh BS, Chattopadhyay S, Gewirtz AT, Joe B, Vijay-Kumar M (2020) Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease. Physiol Genomics 52:217–221 Article...
Coronavirus (SARS-CoV-2), the cause of COVID-19, a fatal disease emerged from Wuhan, a large city in the Chinese province of Hubei in December 2019. The World Health Organization declared COVID-19 as a pandemic due to its spread to other countries inside
[61,62]. The peculiarity of live virus-vectored vaccines is the direct stimulation of the antiviral T-cell response, and intranasal application provides effective stimulation of local immunity. It should be noted that none of the influenza virus vectors used by other research groups have been ...
View PDFView articleView in ScopusGoogle Scholar Peleg and Unger, 2014 Y. Peleg, T. Unger Application of the Restriction-Free (RF) cloning for multicomponents assembly Methods Mol. Biol., 1116 (2014), pp. 73-87 CrossrefView in ScopusGoogle Scholar Pettersen et al., 2021 E.F. Pettersen,...
They are also looking at how the software can be ported to a mobile phone application so that it could be a feasible glaucoma screening tool. By Ximei APP 09/2021 https://www.ximeiapp.com/article/3673866 4. 科兴公布第三剂加强针数据:所产抗体对Delta株中和效力提高2.5倍 ...
No. Type Application Validations Quantity anti-ACE2 antibody ABIN1169449 Primary WB, ELISA, FACS (4) (5) 100 μg anti-ACE2 antibody ABIN1169446 Primary WB, ELISA (1) (1) 100 μg anti-Vimentin antibody (C-Term) ABIN3187471 Primary WB, IHC, ELISA, IF (2) ...
Product Name PID Application/Activity SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.1.7 Variant, Alpha) AG-48B-0003 To measure the presence of neutralizing/blocking antibodies in human serum/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (B.1.1.7 Variant, Alpha) prote...